David Tierney

Dr. David S.
Tierney, MD, is a President, CEO, Secretary, Treasurer & Director at Aramis Biosciences, Inc. He is on the Board of Directors at Bimeda, Inc. and Aramis Biosciences, Inc. Dr. Tierney was previously employed as a Chief Executive Officer by Pharma Two B Ltd., a President & Chief Executive Officer by BioPharmX Corp., an Independent Director by Zevra Therapeutics, Inc., a President & Chief Executive Officer by Icon Bioscience, Inc., a Venture Partner by Signet Healthcare Partners LLC, a President, Chief Operating Officer & Director by Oceana Therapeutics, Inc., an Independent Director by Catalyst Pharmaceuticals, Inc., a President, Chief Executive Officer & Director by Valera Pharmaceuticals, Inc., a President by Biovail Technologies Ltd., a Senior Vice President-Drug Development by Roberts Pharmaceutical Corp., and a Medical Director by Elan Pharmaceuticals, Inc. He also served on the board at Viatar CTC Solutions, Inc., Bioject Medical Technologies, Inc., NexMed, Inc., Able Laboratories, Inc. and Palvella Therapeutics, Inc. He received his doctorate degree from Royal College of Surgeons.